Base to Base biotech podcast 50: Drugs for kidney transplants, glycans, and  drug delivery
Anti-cancer drug gets phase I FDA trials approval
New mass spec platform launched
Approval for prostate cancer treatment
New nanoparticles offer safer, more effective drug delivery
Two key proteins perform powerful functions on a major secretory pathway
RyboDyn joins Lilly Gateway Labs to advance next-gen immunotherapies
Study reveals processes important for skin cancer aggressiveness and identifies two classes of drugs that may block them
FDA Fast Track Designation for gel to treat calciphylaxis ulcers
Exobiosphere and Space Cargo Unlimited unite for high-throughput biotech in space
Saudi Arabia looks to global biotech collaboration
Targeting NK cells may mean more effective immunotherapy in resistant tumours